NEW ORLEANS (AP) -- AstraZeneca PLC’s Crestor cholesterol drug slowed thickening in the neck arteries of people at low risk for heart attacks and strokes, but it failed to reverse thickening as researchers had hoped for.>>> Discuss This Story
NEW ORLEANS (AP) -- AstraZeneca PLC’s Crestor cholesterol drug slowed thickening in the neck arteries of people at low risk for heart attacks and strokes, but it failed to reverse thickening as researchers had hoped for.>>> Discuss This Story
